These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 26318718)

  • 1. Development of a scalable suspension culture for cardiac differentiation from human pluripotent stem cells.
    Chen VC; Ye J; Shukla P; Hua G; Chen D; Lin Z; Liu JC; Chai J; Gold J; Wu J; Hsu D; Couture LA
    Stem Cell Res; 2015 Sep; 15(2):365-75. PubMed ID: 26318718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem Cells.
    Fonoudi H; Ansari H; Abbasalizadeh S; Larijani MR; Kiani S; Hashemizadeh S; Zarchi AS; Bosman A; Blue GM; Pahlavan S; Perry M; Orr Y; Mayorchak Y; Vandenberg J; Talkhabi M; Winlaw DS; Harvey RP; Aghdami N; Baharvand H
    Stem Cells Transl Med; 2015 Dec; 4(12):1482-94. PubMed ID: 26511653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Large-scale production of human pluripotent stem cell derived cardiomyocytes.
    Kempf H; Andree B; Zweigerdt R
    Adv Drug Deliv Rev; 2016 Jan; 96():18-30. PubMed ID: 26658242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The suspension culture of undifferentiated human pluripotent stem cells using spinner flasks.
    Chen VC; Couture LA
    Methods Mol Biol; 2015; 1283():13-21. PubMed ID: 25537838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous WNT Control Enables Advanced hPSC Cardiac Processing and Prognostic Surface Marker Identification in Chemically Defined Suspension Culture.
    Halloin C; Schwanke K; Löbel W; Franke A; Szepes M; Biswanath S; Wunderlich S; Merkert S; Weber N; Osten F; de la Roche J; Polten F; Christoph Wollert K; Kraft T; Fischer M; Martin U; Gruh I; Kempf H; Zweigerdt R
    Stem Cell Reports; 2019 Aug; 13(2):366-379. PubMed ID: 31353227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Large-Scale Production of Cardiomyocytes from Human Pluripotent Stem Cells Using a Highly Reproducible Small Molecule-Based Differentiation Protocol.
    Fonoudi H; Ansari H; Abbasalizadeh S; Blue GM; Aghdami N; Winlaw DS; Harvey RP; Bosman A; Baharvand H
    J Vis Exp; 2016 Jul; (113):. PubMed ID: 27500408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlling expansion and cardiomyogenic differentiation of human pluripotent stem cells in scalable suspension culture.
    Kempf H; Olmer R; Kropp C; Rückert M; Jara-Avaca M; Robles-Diaz D; Franke A; Elliott DA; Wojciechowski D; Fischer M; Roa Lara A; Kensah G; Gruh I; Haverich A; Martin U; Zweigerdt R
    Stem Cell Reports; 2014 Dec; 3(6):1132-46. PubMed ID: 25454631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A massive suspension culture system with metabolic purification for human pluripotent stem cell-derived cardiomyocytes.
    Hemmi N; Tohyama S; Nakajima K; Kanazawa H; Suzuki T; Hattori F; Seki T; Kishino Y; Hirano A; Okada M; Tabei R; Ohno R; Fujita C; Haruna T; Yuasa S; Sano M; Fujita J; Fukuda K
    Stem Cells Transl Med; 2014 Dec; 3(12):1473-83. PubMed ID: 25355733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical-defined and albumin-free generation of human atrial and ventricular myocytes from human pluripotent stem cells.
    Pei F; Jiang J; Bai S; Cao H; Tian L; Zhao Y; Yang C; Dong H; Ma Y
    Stem Cell Res; 2017 Mar; 19():94-103. PubMed ID: 28110125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An intermittent rocking platform for integrated expansion and differentiation of human pluripotent stem cells to cardiomyocytes in suspended microcarrier cultures.
    Ting S; Chen A; Reuveny S; Oh S
    Stem Cell Res; 2014 Sep; 13(2):202-13. PubMed ID: 25043964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac differentiation of human pluripotent stem cells in scalable suspension culture.
    Kempf H; Kropp C; Olmer R; Martin U; Zweigerdt R
    Nat Protoc; 2015 Sep; 10(9):1345-61. PubMed ID: 26270394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lessons from the heart: mirroring electrophysiological characteristics during cardiac development to in vitro differentiation of stem cell derived cardiomyocytes.
    van den Heuvel NH; van Veen TA; Lim B; Jonsson MK
    J Mol Cell Cardiol; 2014 Feb; 67():12-25. PubMed ID: 24370890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Standardized production of hPSC-derived cardiomyocyte aggregates in stirred spinner flasks.
    Kriedemann N; Triebert W; Teske J; Mertens M; Franke A; Ullmann K; Manstein F; Drakhlis L; Haase A; Halloin C; Martin U; Zweigerdt R
    Nat Protoc; 2024 Jul; 19(7):1911-1939. PubMed ID: 38548938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Feeding Strategies on the Scalable Expansion of Human Pluripotent Stem Cells in Single-Use Stirred Tank Bioreactors.
    Kropp C; Kempf H; Halloin C; Robles-Diaz D; Franke A; Scheper T; Kinast K; Knorpp T; Joos TO; Haverich A; Martin U; Zweigerdt R; Olmer R
    Stem Cells Transl Med; 2016 Oct; 5(10):1289-1301. PubMed ID: 27369897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meticulous optimization of cardiomyocyte yields in a 3-stage continuous integrated agitation bioprocess.
    Ting S; Lam A; Tong G; Chen A; Wei H; Wu J; Lam YN; Reuveny S; Oh S
    Stem Cell Res; 2018 Aug; 31():161-173. PubMed ID: 30098478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developing a Cost-Effective and Scalable Production of Human Hepatic Competent Endoderm from Size-Controlled Pluripotent Stem Cell Aggregates.
    Farzaneh Z; Najarasl M; Abbasalizadeh S; Vosough M; Baharvand H
    Stem Cells Dev; 2018 Feb; 27(4):262-274. PubMed ID: 29298619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human cardiomyocyte generation from pluripotent stem cells: A state-of-art.
    Talkhabi M; Aghdami N; Baharvand H
    Life Sci; 2016 Jan; 145():98-113. PubMed ID: 26682938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of Cardiomyocytes from Human Pluripotent Stem Cells by Bioreactor Technologies.
    Halloin C; Coffee M; Manstein F; Zweigerdt R
    Methods Mol Biol; 2019; 1994():55-70. PubMed ID: 31124104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulating cell state to enhance suspension expansion of human pluripotent stem cells.
    Lipsitz YY; Woodford C; Yin T; Hanna JH; Zandstra PW
    Proc Natl Acad Sci U S A; 2018 Jun; 115(25):6369-6374. PubMed ID: 29866848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of Human Pluripotent Stem Cells to Cardiomyocytes Under Defined Conditions.
    van den Berg CW; Elliott DA; Braam SR; Mummery CL; Davis RP
    Methods Mol Biol; 2016; 1353():163-80. PubMed ID: 25626427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.